He goes on to suggest that Graham rework the study\nto say "something like \'This and other studies suggest an increased\nrisk of (acute myocardial infarction with (Vioxx) use and should be\nconsidered by prescribers when making individual treatment\ndecisions.
Even as Merck was deciding to withdraw the drug, there were\nmedical experts arguing that it should not.
Charles Grassley, R-Iowa, who has launched an investigation\ninto the Food and Drug Administration's handling of Vioxx said one of\nthe questions will be whether ``a too cozy relationship between the\nFDA and drug companies is getting in the way of public safety.
